Hallucinations Completed Phase 2 Trials for Pimavanserin (DB05316)

Also known as: Hallucination / Hallucination NOS / Hallucinating / Hallucinations, unspecified

IndicationStatusPhase
DBCOND0003722 (Hallucinations)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00087542Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational DrugTreatment